Neurovalens, a Belfast-based neurotech startup, has made headlines by securing FDA clearance for its pioneering noninvasive device designed to treat generalized anxiety disorder (GAD), showcasing the potential of electrical stimulation technology to address mental health conditions without invasive procedures. This development comes on the heels of the company receiving FDA approval last October for a … Continue reading Neurovalens Secures FDA Clearance for Anxiety Treatment Device